(Q42514219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference

T Motta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

S de Vincentiis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

M Marchini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

N Colombo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

A D'Alberton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

440-442

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia

14 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958113-8

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958113-8

Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958113-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Cabergoline in the long-term therapy of hyperprolactinemic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2958113-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(16)58113-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8566276%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference